Zobrazeno 11 - 20
of 140
pro vyhledávání: '"Hughes-Davies, Luke"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Thomas, Jeremy St John, Provenzano, Elena, Hiller, Louise, Dunn, Janet, Blenkinsop, Clare, Grybowicz, Louise, Vallier, Anne-Laure, Gounaris, Ioannis, Abraham, Jean, Hughes-Davies, Luke, McAdam, Karen, Chan, Stephen, Ahmad, Rizvana, Hickish, Tamas, Houston, Stephen, Rea, Daniel, Caldas, Carlos, Bartlett, John MS, Cameron, David Allan, Hayward, Richard Laurence, Earl, Helena Margaret
Publikováno v:
In Modern Pathology August 2017 30(8):1069-1077
Autor:
Lamb, Alastair D., Thompson, Sue, Kinsella, Netty, Gerbitz, Ingmar, Chapman, Elaine, Putt, Lisa, Bennett, Sophie, Thankappannair, Vineetha, Geoghegan, Lisa, Wright, Naomi, Stirton-Croft, Alison, Nixon, Penny, Styling, Andrew, Whitney, Diane, Hodgson, Lindsay, Punt, Lisa, Longmore, Jenny, Carter, Mike, Petch, Bill, Rimmer, Yvonne, Russell, Simon, Hughes-Davies, Luke, Mazhar, Danish, Shah, Nimish C., Gnanapragasam, Vincent J., Doble, Andrew, Bratt, Ola, Kastner, Christof
Publikováno v:
In European Journal of Oncology Nursing August 2017 29:31-38
Autor:
Earl, Helena M, Hiller, Louise, Dunn, Janet A, Blenkinsop, Clare, Grybowicz, Louise, Vallier, Anne-Laure, Abraham, Jean, Thomas, Jeremy, Provenzano, Elena, Hughes-Davies, Luke, Gounaris, Ioannis, McAdam, Karen, Chan, Stephen, Ahmad, Rizvana, Hickish, Tamas, Houston, Stephen, Rea, Daniel, Bartlett, John, Caldas, Carlos, Cameron, David A, Hayward, Larry
Publikováno v:
In The Lancet Oncology June 2015 16(6):656-666
Autor:
Earl, Helena M, Vallier, Anne-Laure, Hiller, Louise, Fenwick, Nicola, Young, Jennie, Iddawela, Mahesh, Abraham, Jean, Hughes-Davies, Luke, Gounaris, Ioannis, McAdam, Karen, Houston, Stephen, Hickish, Tamas, Skene, Anthony, Chan, Stephen, Dean, Susan, Ritchie, Diana, Laing, Robert, Harries, Mark, Gallagher, Christopher, Wishart, Gordon, Dunn, Janet, Provenzano, Elena, Caldas, Carlos
Publikováno v:
In Lancet Oncology February 2014 15(2):201-212
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Earl, Helena M, Hiller, Louise, Vallier, Anne-Laure, Loi, Shrushma, McAdam, Karen, Hughes-Davies, Luke, Harnett, Adrian N, Ah-See, Mei-Lin, Simcock, Richard, Rea, Daniel, Raj, Sanjay, Woodings, Pamela, Harries, Mark, Howe, Donna, Raynes, Kerry, Higgins, Helen B, Wilcox, Maggie, Plummer, Chris, Mansi, Janine, Gounaris, Ioannis, Mahler-Araujo, Betania, Provenzano, Elena, Chhabra, Anita, Abraham, Jean E, Caldas, Carlos, Hall, Peter S, McCabe, Christopher, Hulme, Claire, Miles, David, Wardley, Andrew M, Cameron, David A, Dunn, Janet A, PERSEPHONE Steering Committee And Trial Investigators
BACKGROUND: Adjuvant trastuzumab significantly improves outcomes for patients with HER2-positive early breast cancer. The standard treatment duration is 12 months but shorter treatment could provide similar efficacy while reducing toxicities and cost
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d38dc3a61d6f5a1d3ff191f5371eef15
Autor:
L, Rooshenas, LJ, Scott, JM, Blazeby, CA, Rogers, KM, Tilling, S, Husbands, C, Conefrey, N, Mills, RC, Stein, C, Metcalfe, AJ, Carr, DJ, Beard, T., Davis, S, Paramasivan, M, Jepson, K, Avery, D, Elliott, C, Wilson, JL, Donovan, Rogers, Chris A., Andrews, Robert, Blazeby, Jane M., Byrne, James, Donovan, Jenny L., Kelly, Jamie, Mazza, Graziella, Mahon, David, Noble, Hamish, Reeves, Barnaby C., Thompson, Janice L., Wordsworth, Sarah, Welbourn, Richard, Beard, David, Carr, Andrew, Cook, Jonathan, Cooper, Cushla, Dean, Benjamin, Gray, Alastair, Gwilym, Stephen, Judge, Andrew, Merritt, Naomi, Moser, Jane, Rees, Jonathan, Rombach, Ines, Savulescu, Julian, Tracey, Irene, Wartolowska, Karolina, Tan, Wei, Mills, Nicola, Karantana, Alexia, Sprange, Kirsty, Duley, Lelia, Elliott, Daisy, Hollingworth, William, Montgomery, Alan A., Davis, Tim, Stein, Rob, Bartlett, John, Cameron, David, Campbell, Amy, Canney, Peter, Dunn, Janet, Earl, Helena, Falzon, Mary, Francis, Adele, Hall, Peter, Harmer, Victoria, Higgins, Helen, Hiller, Louise, Hughes-Davies, Luke, Hulme, Claire, Macpherson, Iain, Makris, Andreas, Marshall, Andrea, McCabe, Christopher, Morgan, Adrienne, Pinder, Sarah, Poole, Christopher, Provenzano, Elena, Rea, Daniel, Stallard, Nigel, Avery, Kerry NL., Barham, C Paul, Berrisford, Richard, Elliott, Jackie, Falk, Stephen J., Goldin, Rob, Hanna, George, Hollowood, Andrew A., Krysztopik, Richard, Metcalfe, Chris, Noble, Sian, Sanders, Grant, Streets, Christopher G., Titcomb, Dan R., Wheatley, Tim
ObjectiveTo evaluate the impact of the Quintet Recruitment Intervention (QRI) on recruitment in challenging randomized controlled trials (RCTs) that have applied the intervention. The QRI aims to understand recruitment difficulties, and then implemen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::a3d1dbfb518c2c540a5d5af0b01c691b
Autor:
Stein, Robert C, Makris, Andreas, Hughes-Davies, Luke, Macpherson, Iain R, Hall, Peter S, Cameron, David A, Earl, Helena M, Pinder, Sarah E, Poole, Christopher J, Rea, Daniel W, McIntosh, Stuart, Harmer, Victoria, Morgan, Adrienne, Rooshenas, Leila, Conefrey, Carmel, Donovan, Jenny L, Hulme, Claire, McCabe, Christopher, Stallard, Nigel, Campbell, Amy, Higgins, Helen, Bartlett, John MS, Marshall, Andrea, Dunn, Janet A
Background: Multi-parameter gene expression assays (MPAs) are widely used to estimate individual patient residual risk in hormone-sensitive HER2-negative node-negative early breast cancer, allowing patients with low risk to safely avoid chemotherapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e700c1509e9938c33c575f2913b8913c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.